General Information of the Compound
| Compound ID |
CP0670151
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
198474-05-4
2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-
3-(5-Fluoro-1H-indol-3-yl)-pyrrolidine-2,5-dione
3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
AKOS027252536
AS-51973
CS-6186
CTK0A0183
DTXSID00630149
EOS200271
EX-A1186
GTPL9565
HY-101111
KS-000008MY
MXKLDYKORJEOPR-UHFFFAOYSA-N
PF-06840003
PF06840003
SCHEMBL5463464
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H9FN2O2
|
||||||||||||||||||
| Molecular Weight |
232.214
|
||||||||||||||||||
| Canonical SMILES |
O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17)
Show/Hide
|
||||||||||||||||||
| InChIKey |
MXKLDYKORJEOPR-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
198474-05-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01557, Indoleamine 2,3-dioxygenase 1
Clinical Information about the Compound